Furthermore, we found that MSI1 and TNS3 expressions are mutually exclusive in migratory tumor lesions and MSI1highTNS3low tumor pattern correlates with poor prognosis for GBM patients These data suggested that MSI1/TNS3 expression ratio could serve as a possible marker to predict survival outcome of GBM patients. The gene discussed is TNS3; the disease is neoplasm.